对比增强CT衍生的细胞外容积分数用于术前预测结直肠癌肿瘤-间质比
该回顾性研究纳入2021年7月至2023年7月接受对比增强CT的结直肠癌患者,训练队列188例、验证队列78例,按病理肿瘤-间质比评分分为高间质组(间质比例>50%)与低间质组(间质比例≤50%)。细胞外容积分数预测高间质比的AUC为0.808(95%CI 0.745-0.872),联合平衡期CT值的模型在训练集与验证集AUC分别为0.811(95%CI 0.748-0.874)与0.733(95%CI 0.623-0.843),与单用细胞外容积分数无显著差异。
要点
- 细胞外容积分数预测高肿瘤-间质比的AUC为0.808(95%CI 0.745-0.872)。
- 高间质组平衡期CT值、静脉期与平扫差值、动脉期强化率及细胞外容积分数均较高(均P<0.05)。
- 细胞外容积分数联合平衡期CT值模型在验证集AUC为0.733(95%CI 0.623-0.843)。
核心结论
- 细胞外容积分数可作为对比增强CT生物标志物用于结直肠癌术前高肿瘤-间质比预测,有望无创评估间质并指导个体化治疗策略。
研究设计与样本
- 回顾性分析2021年7月至2023年7月接受对比增强CT的结直肠癌患者,随机分为训练队列188例和验证队列78例,以组织病理学肿瘤-间质比评分为参考标准。
诊断标准与关键数值
- 以间质比例>50%为高间质组、≤50%为低间质组;细胞外容积分数预测高间质比的AUC为0.808(95%CI 0.745-0.872);联合模型在训练队列AUC为0.811(95%CI 0.748-0.874)、验证队列AUC为0.733(95%CI 0.623-0.843)。
临床应用与阅片要点
- 作者认为细胞外容积分数可作为对比增强CT生物标志物用于术前高肿瘤-间质比预测,并指导个体化治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to investigate the value of contrast-enhanced computed tomography (CECT)-derived extracellular volume (ECV) fraction for preoperative evaluation of tumor-stroma ratio (TSR) in colorectal cancer (CRC).
MATERIALS AND METHODS: We retrospectively analyzed CRC patients who underwent CECT between July 2021 and July 2023. Patients were randomly allocated into a training cohort (n = 188) and a validation cohort (n = 78). Based on histopathological TSR score, patients were stratified into high-TSR (stroma proportion > 50%) and low-TSR (stroma proportion ≤ 50%) groups. Clinical characteristics and CECT parameters were compared and analyzed. Logistic regression analysis was conducted on the training cohort to identify independent predictors for high TSR. Predictive performance was assessed using receiver operating characteristic (ROC) curves, with area under the curve (AUC) differences compared using the Delong test.
RESULTS: In the training cohort, the high-TSR group showed significantly lower non-contrast CT value (CTpre) but higher equilibrium phase CT value (CT EP), the difference between venous phase CT value and CTpre (D-value), arterial phase CT enhancement rate (CER), and ECV fraction (all P < 0.05). The ECV fraction demonstrated the highest predictive performance (AUC = 0.808, 95% confidence interval [CI]: 0.745-0.872). CT EP and ECV fraction were identified as independent predictors for high TSR. A model combining ECV fraction and CT EP yielded AUCs of 0.811 (95% CI: 0.748-0.874) and 0.733 (95% CI: 0.623-0.843) in the training and validation cohorts, respectively, with no significant differences compared to the ECV fraction alone (all P > 0.05).
CONCLUSIONS: The ECV fraction serves as a reliable CECT biomarker for preoperative high TSR prediction in CRC, showing potential for noninvasive stroma evaluation and guiding individualized therapeutic strategies.
引用
- Zhang Y, Zhang H, Li D, et al. Contrast-enhanced CT-derived extracellular volume fraction in preoperative prediction of tumor-stroma ratio in colorectal cancer. Abdom Radiol (NY). 2025. PMID: 40699289. doi:10.1007/s00261-025-05136-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。